Publication | Open Access
Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland
33
Citations
8
References
2016
Year
Golimumab was better in terms of drug survival than infliximab or certolizumab pegol and at least as good as adalimumab and etanercept. Concomitant use of MTX improved drug survival on TNF inhibitors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1